Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Prescription Drug Cost Sharing

Prescription Drug Cost Sharing

  • Be the first to comment

  • Be the first to like this

Prescription Drug Cost Sharing

  1. 1. Prescription Drug Cost Sharing
  2. 2. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Share of Plans by Type of Cost Sharing for Generic Prescriptions Plans with Combined Medical and Prescription Drug Deductible 5% 1% 21% 46% 48% 38% 28% 25% 34% 12% 18% 22% 28% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Copayment & Coinsurance Coinsurance Copayment No Charge after Deductible
  3. 3. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Share of Plans by Type of Cost Sharing for Generic Prescriptions Plans with Separate Medical and Prescription Drug Deductible 17% 20% 2% 98% 82% 78% 97% 2% 1% 1% 1% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Coinsurance Copayment No Charge
  4. 4. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Average Copayment for Generic Drugs $19 $13 $10 $8 $0 $2 $4 $6 $8 $10 $12 $14 $16 $18 $20 Bronze Silver Gold Platinum
  5. 5. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Distribution of Copayment Amounts for Generic Drugs 5% 11% 15% 33% 11% 34% 55% 67% 22% 37% 24% 1% 26% 15% 6% 25% 3% 0% 11% 1% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Over $25 >$20 - $25 >$15 - $20 >$10 - $15 >$5 = $10 $5 or less
  6. 6. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Average Coinsurance Rates for Generic Drugs 30% 29% 23% 26% 0% 5% 10% 15% 20% 25% 30% 35% Bronze Silver Gold Platinum
  7. 7. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Distribution of Coinsurance Rates for Generic Drugs 13% 17% 38% 20% 19% 34% 20% 10% 37% 20% 23% 50% 7% 4% 5% 0% 24% 25% 15% 20% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum 40% or more >30% - >50% >20% - 30% >10% - 20% 10% or less
  8. 8. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Share of Plans by Type of Cost Sharing for Preferred Prescriptions Plans with Combined Medical and Prescription Drug Deductible 36% 17% 8% 26% 58% 69% 91% 38% 26% 23% 9% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Coinsurance Copayment No Charge after Deductible
  9. 9. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Share of Plans by Type of Cost Sharing for Preferred Prescriptions Plans with Separate Medical and Prescription Drug Deductible 81% 94% 93% 99% 19% 6% 7% 1% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Coinsurance Copayment
  10. 10. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Average Copayment for Preferred Drugs $63 $47 $37 $28 $- $10 $20 $30 $40 $50 $60 $70 Bronze Silver Gold Platinum
  11. 11. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Distribution of Copayment Amounts for Preferred Drugs 7% 25% 2% 5% 27% 57% 6% 24% 48% 13% 47% 58% 13% 4% 6% 9% 4% 39% 3% 2% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Over $60 >$50 - $60 >$40 - $50 >$30 - $40 >$20 - $30 20% or less
  12. 12. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Average Coinsurance Rates for Preferred Drugs 32% 30% 27% 27% 24% 25% 26% 27% 28% 29% 30% 31% 32% 33% Bronze Silver Gold Platinum
  13. 13. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Distribution of Coinsurance Rates for Preferred Drugs 2% 10% 17% 18% 24% 19% 12% 36% 39% 52% 64% 11% 11% 8%27% 22% 11% 18% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum 40% or more >30% - >40% >20% - 30% >10% - 20% 10% or less
  14. 14. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Share of Plans by Type of Cost Sharing for Non-Preferred Prescriptions Plans with Combined Medical and Prescription Drug Deductible 36% 20% 8% 20% 40% 52% 88% 44% 40% 40% 11% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Coinsurance Copayment No Charge after Deductible
  15. 15. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Share of Plans by Type of Cost Sharing for Non-Preferred Prescriptions Plans with Separate Medical and Prescription Drug Deductible 56% 75% 78% 69% 44% 25% 22% 31% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Coinsurance Copayment
  16. 16. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Average Copayment for Non-Preferred Drugs $106 $85 $74 $55 $0 $20 $40 $60 $80 $100 $120 Bronze Silver Gold Platinum
  17. 17. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Distribution of Copayment Amounts for Non-Preferred Drugs 1% 4% 8% 60% 34% 47% 66% 35% 30% 39% 22% 4% 27% 9% 2%8% 1% 2% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Over $150 >$100 - $150 >$75 - $100 >$50 - $75 $50 or less
  18. 18. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Average Coinsurance Rates for Non-Preferred Drugs 37% 37% 34% 33% 31% 32% 33% 34% 35% 36% 37% 38% Bronze Silver Gold Platinum
  19. 19. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Distribution of Coinsurance Rates for Non-Preferred Drugs 2% 6% 13% 3% 17% 22% 19% 10% 29% 15% 10% 16% 51% 56% 58% 71% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum >30% - <50% >20% - 30% >10% - 20% 10% or less
  20. 20. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Share of Plans by Type of Cost Sharing for Specialty Prescriptions Plans with Combined Medical and Prescription Drug Deductible 36% 22% 10% 1% 3% 9% 8% 1% 61% 68% 82% 98% 1% 1% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Copayment and Coinsurance Coinsurance Copayment No Charge after Deductible
  21. 21. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Share of Plans by Type of Cost Sharing for Specialty Prescriptions Plans with Separate Medical and Prescription Drug Deductible 12% 33% 34% 33% 88% 67% 65% 67% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Coinsurance Copayment
  22. 22. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Average Copayment for Specialty Drugs $174 $179 $160 $139 $0 $20 $40 $60 $80 $100 $120 $140 $160 $180 $200 Bronze Silver Gold Platinum
  23. 23. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Distribution of Copayment Amounts for Specialty Drugs 16% 8% 15% 39% 25% 47% 58% 23% 39% 23% 13% 28% 12% 14% 5% 2% 8% 8% 8% 8% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum Over $250 >$200 - $250 >$150 - $200 >$100 - $150 $100 or less
  24. 24. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Average Coinsurance Rates for Specialty Drugs 36% 36% 30% 28% 0% 5% 10% 15% 20% 25% 30% 35% 40% Bronze Silver Gold Platinum
  25. 25. SOURCE: Kaiser Family Foundation analysis of Marketplace plans in the 37 states with Federally Facilitated or Partnership exchanges in 2015 (including New Mexico, Oregon, and Nevada). Data are from Healthcare.gov Health plan information for individuals and families available here: https://www.healthcare.gov/health-plan-information/ Distribution of Coinsurance Rates for Specialty Drugs 2% 4% 7% 8% 15% 17% 19% 11% 27% 23% 45% 52% 56% 56% 30% 29% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Bronze Silver Gold Platinum >30% - <50% >20% - 30% >10% - 20% 10% or less

×